Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Poor Glycemic Control”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00111228
What this trial is testing

The Guardcontrol Trial: Study to Assess if Type 1 Diabetics Can Improve Using the Real-time Values of Guardian RT

Who this might be right for
Diabetes Mellitus
Medtronic MiniMed, Inc. 162
Large-scale testing (Phase 3)Study completedNCT01792830
What this trial is testing

Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients

Who this might be right for
Poor Glycemic Control
Emory University 175
Testing effectiveness (Phase 2)Ended earlyNCT00814372
What this trial is testing

Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Gilead Sciences 242
Large-scale testing (Phase 3)Study completedNCT06350890
What this trial is testing

Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Shenzhen HighTide Biopharmaceutical Ltd. 408
Not applicableUnknownNCT03088475
What this trial is testing

A Nurse-led Smartphone-based Self-management Programme for Type 2 Diabetes Patients With Poor Blood Glucose Control

Who this might be right for
Type2 Diabetes Mellitus
National University of Singapore 128
Testing effectiveness (Phase 2)Study completedNCT06849843
What this trial is testing

3mg Once Every Two Weeks Administration of Efsubaglutide Alfa Injection in Type 2 Diabetes Patients.

Who this might be right for
Type2 Diabetes
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. 59
Post-approval studies (Phase 4)Looking for participantsNCT07244003
What this trial is testing

Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 430
Testing effectiveness (Phase 2)Study completedNCT00848315
What this trial is testing

Diabetes Management in Low-Income Hispanic Patients

Who this might be right for
Type 2 DiabetesGlycemic Control
University of Massachusetts, Worcester 252
Large-scale testing (Phase 3)UnknownNCT05326490
What this trial is testing

Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus
PegBio Co., Ltd. 546
Not applicableStudy completedNCT03616275
What this trial is testing

Enhancing the Vagal Tone in Prediabetes Individuals

Who this might be right for
PrediabetesAutonomic Nervous System ImbalancePoor Glycemic Control+1 more
National Defense Medical Center, Taiwan 90
Testing effectiveness (Phase 2)UnknownNCT02917928
What this trial is testing

The Potential of Carnosine Supplementation in Optimising Cardiometabolic Health

Who this might be right for
Poor Glycemic ControlCardiovascular Risk FactorsCognitive Function 1, Social
Monash University 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06777238
What this trial is testing

A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Subjects With Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Gan & Lee Pharmaceuticals. 274
Large-scale testing (Phase 3)UnknownNCT05054842
What this trial is testing

Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 174
Not applicableStudy completedNCT02614729
What this trial is testing

The Consumption of Beef on Appetite and Cognitive Function

Who this might be right for
ObesityPoor Glycemic ControlDietary Interventions
University of Missouri-Columbia 35
Not applicableStudy completedNCT01307566
What this trial is testing

Evolution With CPAP Treatment of a Cohort of Type 2 Diabetic Patients With Apnea-hypopnea Syndrome

Who this might be right for
Sleep ApneaType 2 Diabetes
Hospital de Granollers 50
Large-scale testing (Phase 3)Study completedNCT00174668
What this trial is testing

Insulin Glulisine in Diabetes Mellitus, Type 2

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 311
Not applicableStudy completedNCT01688778
What this trial is testing

Telemedicine as a Means to Achieving Good Diabetes Control Among Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesPoor Glycemic ControlMedication Adherence
Bispebjerg Hospital 165
Large-scale testing (Phase 3)Active Not RecruitingNCT06778967
What this trial is testing

A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Gan & Lee Pharmaceuticals. 1,100
Not applicableStudy completedNCT04667728
What this trial is testing

Professional Continuous Glucose Monitoring as an Adjuvant Educational Tool for Improving Glycemic Control in Patients With Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus, Type 2
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado 302
Post-approval studies (Phase 4)Study completedNCT00372086
What this trial is testing

Rosiglitazone and Insulin in T1DM Adolescents

Who this might be right for
Type 1 DiabetesPuberty: >Tanner 2 Breast Development or Testis >4ml
The University of New South Wales 32
Next Page